The anabolic and anti-apoptotic actions of insulin promote tumor development in hyperinsulinemic subjects through binding of insulin to the insulin receptor (IR), the insulin like growth factor-insulin receptor (IGF-IR) or a hybrid receptor (IR-IGF-IR). This evidence concerns the gene IGF1R and neoplasm.